TLR2, whose well‐known role is to initiate inflammatory responses by recognizing specific products of microbes or host injury, has been reported to be increased in the lesional skin of rosacea patients (Yamasaki et al,2011; Oliveira‐Nascimento et al,2012). The gene discussed is TLR2; the disease is rosacea.